MR Ayush: Prepared For
MR Ayush: Prepared For
Mr Ayush
M 21
fa lse
Health Summary
BLOOD COUNTS
LIPID PROFILE
DIABETES MONITORING
KIDNEY PROFILE
LIVER PROFILE
Everything looks good
Everything looks good
ANEMIA STUDIES
ELECTROLYTES
Test Name Result
Everything looks good RDW-SD 45.3
MCH 32.4
Please Watchout
MINERAL PROFILE
HEMATOLOGY REPORT
Vital Screening Package
Complete Blood Count (CBC)
RBC PARAMETERS
Hemoglobin 14.4 g/dL 13.0 - 17.0
Method : colorimetric
RBC Count 4.4 10^6/µl 4.5 - 5.5
Method : Electrical impedance
PCV 42.3 % 40 - 50
Method : Calculated
MCV 95.1 fl 83 - 101
Method : Calculated
MCH 32.4 pg 27 - 32
Method : Calculated
MCHC 34 g/dL 31.5 - 34.5
Method : Calculated
RDW (CV) 13.4 % 11.6 - 14.0
Method : Calculated
RDW-SD 45.3 fl 35.1 - 43.9
Method : Calculated
WBC PARAMETERS
TLC 5.3 10^3/µl 4 - 10
Method : Electrical impedance and microscopy
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils 48.5 % 40-80
Method : Laser based Flow-cytometry
Lymphocytes 39.6 % 20-40
Method : Laser based Flow-cytometry
Monocytes 9.3 % 2-10
Method : Laser based Flow-cytometry
Eosinophils 2.3 % 1-6
Method : Laser based Flow-cytometry
Basophils 0.3 % <2
Method : Laser based Flow-cytometry
Absolute leukocyte counts
Neutrophils. 2.57 10^3/µl 2-7
Method : Calculated
Lymphocytes. 2.1 10^3/µl 1-3
Method : Calculated
Monocytes. 0.49 10^3/µl 0.2 - 1.0
Method : Calculated
Eosinophils. 0.12 10^3/µl 0.02 - 0.5
Page 1 of 11
Patient Name : Mr Ayush
DOB/Age/Gender : 21 Y/Male Bill Date : Jan 09, 2024, 08:58 AM
Patient ID / UHID : 6773278/RCL5852246 Sample Collected : Jan 09, 2024, 09:13 AM
Referred By : Dr. Sample Received : Jan 09, 2024, 11:50 AM
Sample Type : Whole blood EDTA Report Date : Jan 09, 2024, 12:31 PM
Barcode No : HX871543 Report Status : Final Report
Interpretation:
CBC provides information about red cells, white cells and platelets. Results are useful in the diagnosis of anemia, infections, leukemias, clotting
disorders and many other medical conditions.
Page 2 of 11
Patient Name : Mr Ayush
DOB/Age/Gender : 21 Y/Male Bill Date : Jan 09, 2024, 08:58 AM
Patient ID / UHID : 6773278/RCL5852246 Sample Collected : Jan 09, 2024, 09:13 AM
Referred By : Dr. Sample Received : Jan 09, 2024, 11:50 AM
Sample Type : Whole blood EDTA Report Date : Jan 09, 2024, 01:49 PM
Barcode No : HX871543 Report Status : Final Report
HEMATOLOGY REPORT
Vital Screening Package
Erythrocyte Sedimentation Rate (ESR)
ESR - Erythrocyte Sedimentation Rate 6 mm/hr 0 - 10
Method : MODIFIED WESTERGREN
Interpretation:
ESR is also known as Erythrocyte Sedimentation Rate. An ESR test is used to assess inflammation in the body. Many conditions can cause an
abnormal ESR, so an ESR test is typically used with other tests to diagnose and monitor different diseases. An elevated ESR may occur in
inflammatory conditions including infection, rheumatoid arthritis ,systemic vasculitis, anemia, multiple myeloma , etc. Low levels are typically
seen in congestive heart failure, polycythemia ,sickle cell anemia, hypo fibrinogenemia , etc.
Page 3 of 11
Patient Name : Mr Ayush
DOB/Age/Gender : 21 Y/Male Bill Date : Jan 09, 2024, 08:58 AM
Patient ID / UHID : 6773278/RCL5852246 Sample Collected : Jan 09, 2024, 09:13 AM
Referred By : Dr. Sample Received : Jan 09, 2024, 11:50 AM
Sample Type : Whole blood EDTA Report Date : Jan 09, 2024, 01:51 PM
Barcode No : HX871543 Report Status : Final Report
HEMATOLOGY REPORT
Blood Group ABO & Rh Typing
Blood Group AB - -
Rh Factor Positive - -
Page 4 of 11
Patient Name : Mr Ayush
DOB/Age/Gender : 21 Y/Male Bill Date : Jan 09, 2024, 08:58 AM
Patient ID / UHID : 6773278/RCL5852246 Sample Collected : Jan 09, 2024, 09:13 AM
Referred By : Dr. Sample Received : Jan 09, 2024, 11:50 AM
Sample Type : Serum Report Date : Jan 09, 2024, 12:41 PM
Barcode No : ZB029564 Report Status : Final Report
BIOCHEMISTRY REPORT
Vital Screening Package
Liver Function Test (LFT)
BILIRUBIN TOTAL 0.4 mg/dL 0.2 - 1.2
Method : Photometric
BILIRUBIN DIRECT 0.2 mg/dL 0.0 - 0.5
Method : Diazo Reaction
BILIRUBIN INDIRECT 0.2 mg/dL 0.1 - 1.0
Method : Calculation (T Bil - D Bil)
SGOT/AST 18 U/L 11 - 34
Method : Enzymatic NADH (without P5P)
SGPT/ALT 12.4 U/L < 45
Method : Enzymatic NADH (without P5P)
SGOT/SGPT Ratio 1.45 % -
Method : Calculated
ALKALINE PHOSPHATASE 73 U/L 40 - 150
Method : Photometric (Para-Nitrophenyl Phosphate)
TOTAL PROTEIN 7.3 g/dL 6.4 - 8.3
Method : Biuret (Photometric)
ALBUMIN 4.93 g/dL 3.5 - 5.2
Method : Colorimetric BCG
GLOBULIN 2.37 g/dL 2.3 - 3.5
Method : Calculation (T.P - Albumin)
ALBUMIN : GLOBULIN RATIO 2.08 - 1.3 - 2.1
Method : Calculation (Albumin/Globulin)
GAMMA GLUTAMYL TRANSFERASE (GGT) 12.7 U/L < 55
Method : Photometric
Interpretation:
The liver filters and processes blood as it circulates through the body. It metabolizes nutrients, detoxifies harmful substances, makes blood
clotting proteins, and performs many other vital functions. The cells in the liver contain proteins called enzymes that drive these chemical
reactions. When liver cells are damaged or destroyed, the enzymes in the cells leak out into the blood, where they can be measured by blood
tests Liver tests check the blood for two main liver enzymes. Aspartate aminotransferase (AST),SGOT: The AST enzyme is also found in
muscles and many other tissues besides the liver. Alanine aminotransferase (ALT), SGPT: ALT is almost exclusively found in the liver. If ALT
and AST are found together in elevated amounts in the blood, liver damage is most likely present. Alkaline Phosphatase and GGT: Another of
the liver's key functions is the production of bile, which helps digest fat. Bile flows through the liver in a system of small tubes (ducts), and is
eventually stored in the gallbladder, under the liver. When bile flow is slow or blocked, blood levels of certain liver enzymes rise: Alkaline
phosphatase Gamma-utamyl transpeptidase (GGT) Liver tests may check for any or all of these enzymes in the blood. Alkaline phosphatase is
by far the most commonly tested of the three. If alkaline phosphatase and GGT are elevated, a problem with bile flow is most likely present. Bile
flow problems can be due to a problem in the liver, the gallbladder, or the tubes connecting them. Proteins are important building blocks of all
cells and tissues. Proteins are necessary for your body's growth, development, and health. Blood contains two classes of protein, albumin and
globulin. Albumin proteins keep fluid from leaking out of blood vessels. Globulin proteins play an important role in your immune system. Low
total protein may
indicate:
1.bleeding
Page 5 of 11
Patient Name : Mr Ayush
DOB/Age/Gender : 21 Y/Male Bill Date : Jan 09, 2024, 08:58 AM
Patient ID / UHID : 6773278/RCL5852246 Sample Collected : Jan 09, 2024, 09:13 AM
Referred By : Dr. Sample Received : Jan 09, 2024, 11:50 AM
Sample Type : Serum Report Date : Jan 09, 2024, 12:41 PM
Barcode No : ZB029564 Report Status : Final Report
caused by:
1.A poor diet (malnutrition).
2.Kidney disease.
3.Liver disease. High albumin levels may be caused by: Severe dehydration.
Page 6 of 11
Patient Name : Mr Ayush
DOB/Age/Gender : 21 Y/Male Bill Date : Jan 09, 2024, 08:58 AM
Patient ID / UHID : 6773278/RCL5852246 Sample Collected : Jan 09, 2024, 09:13 AM
Referred By : Dr. Sample Received : Jan 09, 2024, 11:50 AM
Sample Type : Serum Report Date : Jan 09, 2024, 12:41 PM
Barcode No : ZB029564 Report Status : Final Report
BIOCHEMISTRY REPORT
Vital Screening Package
Kidney Function Test (KFT)
BLOOD UREA 22.8 mg/dL 19 - 44.1
Method : Urease
CREATININE 0.8 mg/dL 0.6 - 1.2
Method : Kinetic Alkaline Picrate
BUN 10.65 mg/dL 6 - 20
Method : Calculated
BUN/CREATININE RATIO 13.31
Method : Calculated
UREA / CREATININE RATIO 28.5
URIC ACID 6.14 mg/dL 3.7 - 7.7
Method : Uricase
CALCIUM Serum 9.2 mg/dL 8.4 - 10.2
Method : Arsenazo III
PHOSPHORUS 4.5 mg/dL 2.3 - 4.7
Method : Photometric
SODIUM 141.3 mmol/L 136 - 145
Method : Potentiometric
POTASSIUM 4.4 mmol/L 3.5 - 5.1
Method : Potentiometric
CHLORIDE 105.2 mmol/L 98 - 107
Method : Potentiometric
Interpretation:
Kidney function tests is a collective term for a variety of individual tests and proceduresthat can be done toevaluate how well the kidneys are functioning. Many
conditions can affect the ability of the kidneys to carryout their vital functions. Somelead to a rapid (acute) decline in kidney functionothers lead to a gradual
(chronic) declineinfunction. Both result in a buildup of toxic waste subst done on urine samples, as well as on blood samples. A number of symptoms may
indicate a problem with your kidneys. These include : high blood pressure,blood in urine frequent urges to urinate,difficulty beginning urination,painful
urination,swelling in the hands and feet due to a buildup of fluids in the body. A single symptom may not mean something serious. However, when occurring
simultaneously, these symptoms suggest that your kidneys are not working properly. Kidney function tests can help determine the reason. Electrolytes
(sodium,potassium,and chloride) are present in the human body and the balancing act of the electrolytes in our bodies is essential for normal function of our cells
and organs. There has to be a balance.Ionized calcium this test if you have signs of kidney or parathyroid disease. The test may also be done to monitor progress
and treatment of these diseases.
Page 7 of 11
Patient Name : Mr Ayush
DOB/Age/Gender : 21 Y/Male Bill Date : Jan 09, 2024, 08:58 AM
Patient ID / UHID : 6773278/RCL5852246 Sample Collected : Jan 09, 2024, 09:13 AM
Referred By : Dr. Sample Received : Jan 09, 2024, 11:50 AM
Sample Type : Serum Report Date : Jan 09, 2024, 12:41 PM
Barcode No : ZB029564 Report Status : Final Report
BIOCHEMISTRY REPORT
Vital Screening Package
Lipid Profile
TOTAL CHOLESTEROL 164 mg/dL <200
Method : Enzymatic
TRIGLYCERIDES 46 mg/dL <150
Method : Photometric
HDL CHOLESTEROL 60 mg/dL > 40
Method : Accelerator Selective Detergent
NON HDL CHOLESTEROL 104 mg/dL <130
Method : Calculated
LDL CHOLESTEROL 94.8 mg/dL <100
Method : Calculated
V.L.D.L CHOLESTEROL 9.2 mg/dL < 30
Method : Calculated
CHOL/HDL Ratio 2.73 Ratio -
Method : Calculated
HDL/ LDL RATIO 0.63 Ratio -
Method : Calculated
LDL/HDL Ratio 1.58 Ratio -
Method : Calculated
Interpretation:
Lipid level assessments must be made following 9 to 12 hours of fasting, otherwise assay results might lead to erroneous interpretation. NCEP recommends of 3
different samples to be drawn at intervals of 1 week for harmonizing biological variables that might be encountered in single assays.
National Lipid Association Recommendations Total Cholesterol Triglyceride LDL Cholesterol Non HDL Cholesterol
(NLA-2014) (mg/dL) (mg/dL) (mg/dL) (mg/dL)
Optimal <200 <150 <100 <130
Above Optimal 100-129 130 - 159
Borderline High 200-239 150-199 130-159 160 - 189
High >=240 200-499 160-189 190 - 219
Very High - >=500 >=190 >=220
HDL Cholesterol
Low High
<40 >=60
Risk Stratification for ASCVD (Atherosclerotic Cardiovascular Disease) by Lipid Association of India.
Page 8 of 11
Patient Name : Mr Ayush
DOB/Age/Gender : 21 Y/Male Bill Date : Jan 09, 2024, 08:58 AM
Patient ID / UHID : 6773278/RCL5852246 Sample Collected : Jan 09, 2024, 09:13 AM
Referred By : Dr. Sample Received : Jan 09, 2024, 11:50 AM
Sample Type : Serum Report Date : Jan 09, 2024, 12:41 PM
Barcode No : ZB029564 Report Status : Final Report
Newer treatment goals and statin initiation thresholds based on the risk categories proposed by Lipid Association of India
in 2020.
References : Management of Dyslipidaemia for the Prevention of Stroke : Clinical practice Recommendations from the Lipid Association of
India. Current Vascular Pharmacology,2022,20,134-155.
Page 9 of 11
Patient Name : Mr Ayush
DOB/Age/Gender : 21 Y/Male Bill Date : Jan 09, 2024, 08:58 AM
Patient ID / UHID : 6773278/RCL5852246 Sample Collected : Jan 09, 2024, 09:13 AM
Referred By : Dr. Sample Received : Jan 09, 2024, 11:50 AM
Sample Type : Spot Urine Report Date : Jan 09, 2024, 12:33 PM
Barcode No : YA111029 Report Status : Final Report
Page 10 of 11
Patient Name : Mr Ayush
DOB/Age/Gender : 21 Y/Male Bill Date : Jan 09, 2024, 08:58 AM
Patient ID / UHID : 6773278/RCL5852246 Sample Collected : Jan 09, 2024, 09:13 AM
Referred By : Dr. Sample Received : Jan 09, 2024, 11:50 AM
Sample Type : Spot Urine Report Date : Jan 09, 2024, 12:33 PM
Barcode No : YA111029 Report Status : Final Report
Page 11 of 11
Terms and Conditions of Reporting
1. The presented findings in the Reports are intended solely for informational and interpretational purposes by the
referring physician or other qualified medical professionals possessing a comprehensive understanding of
reporting units, reference ranges, and technological limitations. The laboratory shall not be held liable for any
interpretation or misinterpretation of the results, nor for any consequential or incidental damages arising from
such interpretation.
2. It is to be presumed that the tests performed pertain to the specimen/sample attributed to the Customer's name
or identification. It is presumed that the verification particulars have been cleared out by the customer or his/her
representation at the point of generation of said specimen / sample. It is hereby clarified that the reports
furnished are restricted solely to the given specimen only.
3. It is to be noted that variations in results may occur between different laboratories and over time, even for the
same parameter for the same Customer. The assays are performed and conducted in accordance with standard
procedures, and the reported outcomes are contingent on the specific individual assay methods and equipment(s)
used, as well as the quality of the received specimen.
4. This report shall not be deemed valid or admissible for any medico-legal purposes.
5. The Customers assume full responsibility for apprising the Company of any factors that may impact the test
finding. These factors, among others, includes dietary intake, alcohol, or medication / drug(s) consumption, or
fasting. This list of factors is only representative and not exhaustive.
+ +
SMART HEALTH REPORT
RT
MC-5280
+
Experience With Accurate Reports With Quick Results